Bristol-Myers Squibb Co (NYSE: BMY)

DRUGS - Drug Manufacturers - Major
Sector: Health Care

Stock price data as of 04/26/2024

Closing price: 44.85

Support price level:	N/A
Resistance price level:	$47.62
Relative strength index (14-day RSI)	20.5
Beta	0.37

BMY is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
With a -34.1 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
BMY is one of this month's worst performers with a return of -17.3%, underperforming 90 percent of stocks in the S&P-100.
Down 8.3 percent, BMY is one of this week's biggest decliners.
Volatility is forecast to fall over the next month.
With RSI < 30, BMY is oversold. Odds slightly favor a short-term price reversal.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$44.70	$69.08	0.8%

200 day	50 day	20 day	10 day
$54.11	$50.93	$49.47	$47.84

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
22.3%	19.6%	34.2%	28.6%

There is an estimated 5% probability that the stock price of Bristol-Myers Squibb Co will fall by more than: